Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

867
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
867
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

1.5K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.5K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

2.0K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.0K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of Lepton-Jet Correlation in Deep-Inelastic Scattering with the H1 Detector Using Machine Learning for Unfolding.

Physical review letters·2022
Same author

Determination of the strong coupling constant <math> </math> in next-to-next-to-leading order QCD using H1 jet cross section measurements: H1 Collaboration.

The European physical journal. C, Particles and fields·2020
Same author

[BIOLOGICALLY ACTIVE ALKALOIDS FROM RHIZOMES WITH ROOTS OF VINCA HERBACEA WALDST. ET KIT, GROWING IN GEORGIA].

Georgian medical news·2017
Same author

Preliminary phytochemical and biological evaluation of daphne glomerata extracts.

Georgian medical news·2014
Same author

Ivy water extracts as gastric ulcer preventive agents.

Georgian medical news·2013
Same author

Cholinergic stimulation of adrenal medulla is essential for the granulicytopoietic response to lithium.

Georgian medical news·2012

Related Experiment Video

Updated: Mar 2, 2026

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.6K

[ANTISEIZURE ACTIVITY OF C EPHALARIA GIGANTEA ROOT EXTRACT].

N Gogitidze1, N Mushkiashvili1, M Gedevanishvili1

  • 1Tbilisi State Medical University I.Kutateladze Institute of Pharmacochemistry; Iv. Javakhishvili Tbilisi State University, Georgia.

Georgian Medical News
|May 9, 2017
PubMed
Summary

Cephalaria gigantea root extract shows significant antiseizure effects in rat models, effectively reducing seizure activity and mortality. This traditional anticonvulsant remedy also exhibits sedative properties and moderate toxicity.

More Related Videos

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

10.1K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.7K

Related Experiment Videos

Last Updated: Mar 2, 2026

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.6K
Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

10.1K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.7K

Area of Science:

  • Pharmacology
  • Neuroscience
  • Ethnobotany

Background:

  • Cephalaria gigantea root extract is traditionally used in Georgian folk medicine as an anticonvulsant.
  • Anticonvulsant properties of this extract have not been experimentally validated.
  • Understanding the efficacy and safety of traditional remedies is crucial for modern medicine.

Purpose of the Study:

  • To experimentally evaluate the antiseizure activity of Cephalaria gigantea root extract.
  • To assess the extract's efficacy in different seizure models and administration routes.
  • To investigate potential sedative effects and overall toxicity of the extract.

Main Methods:

  • Antiseizure activity was tested using pentylenetetrazole (PTZ)-induced seizures and audiogenic seizures in rats.
  • Key parameters evaluated included seizure onset, latency, mortality, and behavioral convulsive reactions.
  • Sedative properties were assessed by observing sleep prolongation in mice treated with barbiturates, alongside toxicological studies.

Main Results:

  • The Cephalaria gigantea root extract demonstrated significant anticonvulsant properties in both PTZ and audiogenic seizure models.
  • Repetitive administration of the extract was most effective, eliminating seizures in 90% of PTZ-treated rats and preventing observable convulsions for 7 days post-treatment in audiogenic models.
  • The extract exhibited sedative effects and was classified as having moderate general toxicity following acute and chronic toxicological assessments.

Conclusions:

  • Cephalaria gigantea root extract possesses experimentally validated anticonvulsant properties.
  • The extract is most effective with repeated administration and shows moderate toxicity, suggesting therapeutic potential.
  • Further research into the active compounds and mechanisms of action is warranted for this traditional remedy.